CARBON MONOXIDE DIFFUSING CAPACITY DECREASED

This adverse event was reported 170 times

CARBON MONOXIDE DIFFUSING CAPACITY DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VINBLASTINE SULFATE 5 0.0025
1 BLEOMYCIN SULFATE 9 0.0009
2 DACARBAZINE 6 0.0008
3 PIRFENIDONE 31 0.0008
4 APREPITANT 4 0.0005
5 PEGFILGRASTIM 4 0.0003
6 CICLESONIDE 4 0.0003
7 FOSAPREPITANT DIMEGLUMINE 4 0.0003
8 TIMOLOL 3 0.0002
9 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 3 0.0002
See all drugs enriched for association with CARBON MONOXIDE DIFFUSING CAPACITY DECREASED